Charles River Laboratories International Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | $821.0M | $733.1M | $117.9M |
| FY2016 | $1.19B | $836.8M | $117.6M |
| FY2017 | $1.09B | $1.05B | $163.8M |
| FY2018 | $1.63B | $1.32B | $195.4M |
| FY2019 | — | $1.63B | $238.0M |
| FY2020 | — | $2.11B | $228.4M |
| FY2021 | — | $2.53B | $241.2M |
| FY2022 | — | $2.98B | $233.9M |
| FY2023 | — | $3.60B | $276.8M |
| FY2024 | — | $3.46B | $194.6M |